Examkin

Soru

Zorluk: OrtaPharmacologic Interventions

A triage nurse calls the physician to immediately evaluate a patient who just arrived with profound muscle weakness. The patient is a 57-year-old male with a history of hypertension, type 2 diabetes mellitus, and end-stage renal disease who reports missing his last two scheduled hemodialysis sessions due to severe regional weather. He complains of a heavy sensation in his limbs and perioral numbness that began earlier today. His blood pressure is 150/88 mmHg, heart rate is 52/min, and respiratory rate is 18/min. Cardiopulmonary auscultation is unremarkable, but neurologic examination reveals symmetric 3/5 weakness in the proximal and distal muscles of all four limbs. An urgent 12-lead electrocardiogram is obtained and displays significantly peaked T waves, flattened P waves, and a widened QRS complex. A venous blood gas analysis indicates a serum potassium concentration of 7.9 mEq/L.

Arrange the following pharmacologic therapies in the correct chronological sequence for the acute management of this life-threatening presentation.

  1. 1Administer intravenous calcium gluconate
  2. 2Administer intravenous regular insulin and 50% dextrose
  3. 3Administer oral sodium polystyrene sulfonate

Cevap

The correct sequential order for managing life-threatening hyperkalemia is to first administer intravenous calcium gluconate to stabilize the cardiac membrane, followed by intravenous regular insulin and 50% dextrose to temporarily shift potassium intracellularly, and finally oral sodium polystyrene sulfonate to definitively eliminate potassium from the body.
The exact chronological order leverages the onset of action of each drug to prevent mortality. Calcium gluconate works within 1 to 3 minutes to stabilize the myocardium. Insulin and dextrose work within 15 to 30 minutes to temporarily shift potassium into cells. Sodium polystyrene sulfonate takes 2 to 6 hours to definitively remove potassium from the body.

Adım Adım Çözüm

1
Identify life-threatening hyperkalemia with cardiac toxicity.
The patient's ECG shows peaked T waves and widened QRS complexes, correlating with a severe potassium level of 7.9 mEq/L.
Recognizing electrical instability dictates the immediate need for cardioprotective measures before attempting to lower the potassium level.
2
Administer a cardioprotective agent.
Intravenous calcium gluconate is placed in the first position.
To rapidly stabilize the myocardial resting membrane potential and prevent imminent lethal arrhythmias.
3
Initiate temporary potassium-shifting therapy.
Intravenous regular insulin with 50% dextrose is placed in the second position.
To quickly drive extracellular potassium into the cells (onset 15-30 minutes), thereby temporarily lowering the serum potassium concentration while waiting for definitive elimination.
4
Administer a definitive potassium-eliminating therapy.
Oral sodium polystyrene sulfonate is placed in the third position.
To definitively remove excess potassium from the body via the gastrointestinal tract, noting that this step takes several hours to take effect.

Anahtar Kavram

In the acute management of severe hyperkalemia with electrocardiographic changes, therapy must follow a strict physiologic sequence: cardiac membrane stabilization (intravenous calcium), followed by rapid intracellular potassium shifting (intravenous insulin/glucose, beta-agonists), and finally total body potassium elimination (diuretics, gastrointestinal binders, or hemodialysis).
Tahmini Süre:1m 15s
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru